Immunorock
Developer of a biopharmaceutical platform designed to accelerate the clinical translation of academic discoveries into immunotherapies. The company's platform offers an oral cancer vaccine using genet...
Valuation
$8.5M
Market implied
Share Price
N/A
Total Raised
$2.3M
Last Round
N/A